Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

GREY:IVITF - Post Discussion

Invictus MD Strategies Corp > Still belive in this company
View:
Post by ManUnited on Nov 05, 2019 11:05am

Still belive in this company

This team makes a lot of wise decisions. Selling assets which are not profitable at the moment is hard but right. Even the biggest players in this industry are doing exactly the same right now. No matter if it´s Aurora, Canopy or Hexo, all of them are doing a radical cut to reach profitabiliy as soon as possible. I´m sorry for the people at INVICTUS who lost their jobs, but it´s a necessary step to ensure the safety of the whole company. Liquidity is the most important thing at this stage. Hopefully INVICTUS can complete the so called "east-wing" very soon, bad enough that we depend on Health Canada who are doing a really bad job. Let´s hope for good news in december.
Comment by HEY3189 on Nov 05, 2019 11:39am
This post has been removed in accordance with Community Policy
Comment by HeryRunFst2 on Nov 07, 2019 2:08pm
This post has been removed in accordance with Community Policy
Comment by gamos99 on Nov 08, 2019 12:34pm
GENE's bottom is in aroudn $0.15 .. after several months of 'negative' news releases (cancelled deals and fees paid to get out of contracts), we saw our first 'positive' news release in quite a while this week.   Check out the green vs. red volume over the past month.
Comment by gamos99 on Nov 08, 2019 12:35pm
Comment by gamos99 on Nov 08, 2019 12:37pm
Gene trading chart past month
Comment by wictor11 on Nov 12, 2019 8:38pm
Where s our evangelist gene to the rescue, what a joke of a company,
Comment by display_name on Nov 12, 2019 11:50pm
They've made poor marketing decisions but kept a core set of producing assets. Not as ideal as having made good marelying decisions plus maintaining core assets but still much better than plenty of the deadwood in this sector which went all in on market branding without vertically integrated assets. I'm minorly displeased with marketing but not overly concerned. Marketing mishaps yes, but ...more  
Comment by FewGoodMen on Nov 17, 2019 6:46pm
This post has been removed in accordance with Community Policy
Comment by UPhaskdgd on Nov 17, 2019 7:24pm
This post has been removed in accordance with Community Policy
Comment by HEYthereGuYs on Nov 18, 2019 3:01pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities